Therapeutic extracellular vesicles, derived from HEK293T cells expressing the NFAT3 transcription factor, are used in the advanced treatment of metastatic triple-negative breast cancer and pancreatic cancer.
Our technologies Our technologies
Therapeutic extracellular vesicles, derived from HEK293T cells expressing the NFAT3 transcription factor, are used in the advanced treatment of metastatic triple-negative breast cancer and pancreatic cancer.
Spacetime-constrained oblivious transfer (SCOT) is a cryptographic task extending one-out-of-m oblivious transfer (OT) by guaranteeing security from quantum physics and relativistic signalling constraints.
Use of anti-miRNAs as therapeutic tools in HER2+ breast cancer.
Compounds releasing carbon monoxide (CO-RMS) are being investigated as a new treatment approach to mitigate age-related metabolic dysfunction.
New optimization algorithm based on fractal decomposition. Thanks to a new approach of covering space this algorithm can solve problems with a large number of variables while providing an exact answer. All this with a very low complexity (logarithmic).
Automated (unsupervised) subsequence anomalies detection in a time series
New heat exchanger based on low cost material, easy to install and maintain. It is based on a flexible polymer tructure and left free in a moving external fluid.
A new formulation excipient-free and based on nanocrystals, improving biodisponibility & dose efficacy. The first indication developed for this technology is a new formulation of Etoposide, a commonly used molecule to treat several cancers.
Research is one of the building blocks of societal progress. It shapes a playground in which commitment and investment must participate in global and virtuous evolution for the greatest number of people.
Erganeo is at your disposal.